Nautilus Biotechnology, Inc. - Common Stock — Liquidità (NASDAQ:NAUT) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative —-39.24 M-45.81 M-51.71 M-59.15 M-50.7 M -49.86 M Flussi di cassa derivanti dalle attività di investimento —-138.96 M-25.74 M-43.73 M66.25 M35.22 M 29.95 M Liquidità derivante dalle attività di finanziamento —327.45 M562 K368 K1.14 M214 K 1.3 M Liquidità libera —-39.24 M-45.81 M-51.71 M-59.15 M-51.97 M -51.43 M

Notizie

3 Small-Cap Stocks to Buy Before May 15

Brain Computer Interface Stocks: 10 Plays Beyond Neuralink

Nautilus Biotechnology all’Investor Summit: percorso innovativo nella proteomica

Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Nautilus Biotechnology appoints Amber Faust as VP of sales

AMD, IONQ: Amazon Exits Stakes in Advanced Micro Devices and IonQ - TipRanks.com

Nautilus Biotechnology al Q3 Investor Summit: La spinta della proteomica

Nautilus Biotechnology at Q3 Investor Summit: Proteomics Push

Nautilus at Goldman Sachs Conference: Proteomics Market Potential

Nautilus: Trading Below An Albeit Lower Net Cash Figure (NASDAQ:NAUT)

Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Earnings Call Transcript

Nautilus Biotechnology, Inc. 2024 Q4 - Results - Earnings Call Presentation (NASDAQ:NAUT)